Skip to main content
. 2023 Apr 20;38:103414. doi: 10.1016/j.nicl.2023.103414

Table 2.

Participant characteristics.

Variable Total (n = 37) Neuropathic Pain Intensity Nociceptive
Pain Intensity
Demographics
Age (years) 41.24 ± 13.48 τ = 0.13, p = 0.29 τ = -0.03, p = 0.84
Male 30 (81.1) W = 117, p = 0.53 W = 137, p = 0.88
Pain Phenotype
No pain 6 (16.2)
Neuropathic pain 26 (70.3)
 Only neuropathic pain 14 (37.8)
Nociceptive pain 17 (45.9)
 Only nociceptive pain 5 (13.5)
Neuropathic + Nociceptive Pain 12 (32.4)
Injury Characteristics
Injury duration (years) 10.17 ± 8.05 τ = 0.06, p = 0.62 τ = 0.17, p = 0.17
Tetraplegia 5 (13.5) W = 74, p = 0.35 W = 107, p = 0.58
AIS classification*
  • A

  • B

  • C


26/36 (72.2)
6/36 (16.7)
4/36 (11.1)
H(2) = 2.82, p = 0.24 H(2) = 0.65, p = 0.72
Active Medication Use
Opioid 10 (27.0) W = 235, p = 0.12 W = 209, p = 0.50
Gabapentin 5 (13.5) W = 144, p = 0.03 W = 76, p = 0.37
ISCIPBDS Pain Ratings
Worst neuropathic 5.92 ± 2.35 τ = 0.04, p = 0.78
Worst nociceptive 4.71 ± 1.61 τ = 0.04, p = 0.78

Continuous variables are presented as mean ± SD and categorical variables as N (%). *Data provided includes the full sample of participants (n = 37) except for AIS classification (n = 36). American Spinal Injury Association Impairment Scale (AIS), International Spinal Cord Injury Pain Basic Dataset (ISCIPBDS). Associations of participant characteristics with worst neuropathic and nociceptive pain intensities rated on the ISCIPBDS are reported from Kendall’s Tau (τ) for continuous variables and Wilcoxon Rank-Sum (W) or Kruskal-Wallis (H) tests for categorical variables.